Principal Causes of Death in Leptospirosis
The primary causes of death in leptospirosis are pulmonary hemorrhage (accounting for approximately 47-55% of fatal cases), followed by acute respiratory distress syndrome, multiorgan failure, and cardiovascular complications including shock and arrhythmias 1, 2, 3, 4.
Respiratory Complications as the Leading Cause
Pulmonary hemorrhage and acute respiratory distress syndrome represent the most lethal manifestations of severe leptospirosis, with death typically occurring within 72 hours of symptom onset 5. In contemporary ICU cohorts, alveolar hemorrhage independently predicts mortality with an adjusted odds ratio of 7.91 2. The leptospirosis-associated pulmonary hemorrhagic syndrome (LPHS) carries approximately 50% mortality and is characterized by massive pulmonary hemorrhage, coughing, chest pain, and dyspnea 5.
The pathophysiology involves both direct vascular damage from Leptospira and immune-mediated disruption of endothelial integrity through cytokine release, adhesion molecule expression, and complement activation 5. Clinically, the presence of pulmonary rales on admission increases death risk 5.2-fold 4.
Cardiovascular Collapse
Shock and cardiac complications constitute the second major pathway to death. Shock is the strongest independent predictor of severe leptospirosis (OR 14.8) and frequently precedes death 3. Cardiac arrhythmias independently predict mortality with an adjusted odds ratio of 13.82 2. Hypotension on admission increases death risk 10.3-fold 4.
Renal and Metabolic Derangements
While hepatorenal failure characterizes severe Weil's disease 1, isolated renal dysfunction has become less prognostically significant with timely renal replacement therapy 2. However, severe renal impairment remains a marker of disease severity—urea >180 mg/dL independently predicts mortality (aOR 9.01) 2. Oliguria increases death risk 8.8-fold, and hyperkalemia increases it 5.9-fold 4.
Hemorrhagic Complications
Hemorrhage beyond pulmonary involvement independently predicts death (OR 71.2) 3. Severe thrombocytopenia (<45 × 10³/mm³) carries an adjusted odds ratio of 14.07 for mortality 2. The bleeding results from capillary fragility rather than coagulopathy, as clotting tests often remain normal despite significant hemorrhage 1.
Clinical Recognition Algorithm
Identify patients at highest mortality risk by assessing for:
- Respiratory: Pulmonary rales, dyspnea, hemoptysis, oxygen requirement
- Cardiovascular: Hypotension, shock requiring vasopressors, arrhythmias
- Renal: Oliguria, urea >180 mg/dL, hyperkalemia
- Hematologic: Platelet count <45 × 10³/mm³, active hemorrhage
- Hepatic: Jaundice (though less predictive of mortality than respiratory/cardiac complications)
Critical Pitfalls
The immune phase of leptospirosis (occurring 1-3 days after initial bacteremia) is when severe complications manifest 1. Patients may initially appear to improve before rapid deterioration—this biphasic pattern demands continued vigilance even after initial stabilization.
Prior steroid use increases mortality risk 20-fold 3, likely by impairing immune responses during the critical immune phase when severe disease is "probably immunologically mediated" 1.
Geographic variation exists: residing in Brazil's Southeast region increases death risk by 83% compared to the North 6, highlighting the importance of local healthcare infrastructure and early recognition.
The mortality rate ranges from 19-28% in severe cases requiring ICU admission 2, 3, with overall leptospirosis mortality around 10-20% 6. Death occurs rapidly—typically within 72 hours of severe pulmonary manifestations 5, necessitating aggressive early intervention when risk factors are identified.